Related Experiment Video

Updated: Jul 19, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

[Monocyte chemotactic protein-1 expression in coronary atherosclerosis plaque of sudden coronary death patients]

Xiang-ping Feng1, Wen-bin Dong, Xin-shan Chen

  • 1Faculty of Forensic Medicine, Wenzhou Medical College, Wenzhou 325035, China. fxp@wzmc.net

Zhonghua Xin Xue Guan Bing Za Zhi
|November 4, 2006
PubMed

Insights

Monocyte chemotactic protein 1 (MCP-1) expression is elevated in the coronary atherosclerosis plaques of sudden coronary death (SCD) patients, indicating its role in the condition.

Area of Science:

  • Cardiovascular Pathology
  • Immunology
  • Molecular Biology

Background:

  • Coronary atherosclerosis is a leading cause of death.
  • Sudden coronary death (SCD) is often linked to advanced atherosclerosis.
  • The role of specific inflammatory markers in SCD requires further elucidation.

Purpose of the Study:

  • To quantify monocyte chemotactic protein 1 (MCP-1) expression in coronary atherosclerotic plaques.
  • To determine the association between MCP-1 levels and SCD.
  • To compare MCP-1 expression in SCD patients versus control groups.

Main Methods:

  • Analysis of autopsy heart samples from 90 individuals (36 SCD, 28 non-SCD CHD, 26 non-cardiac death).
  • Utilized immunohistochemistry SABC techniques to detect MCP-1.
  • Employed computerized image analysis to quantify positive MCP-1 cell area.

Main Results:

  • MCP-1 expression (both R and A metrics) was significantly higher in the SCD group compared to non-SCD CHD and non-cardiac death control groups (P=0.04 and P=0.00).
  • No significant difference in MCP-1 expression was observed between the two control groups.
  • These findings suggest a strong correlation between elevated MCP-1 and SCD.

Conclusions:

  • MCP-1 expression is significantly increased in coronary atherosclerotic plaques of SCD patients.
  • Elevated MCP-1 may be a key factor contributing to the pathogenesis of SCD.
  • Further research into MCP-1's role could inform therapeutic strategies for preventing SCD.
Abstract

More Related Videos

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...